Where in-person care matters, we offer in-home urgent care visits in select markets
From there, we create a personalized, medically supervised plan designed to help you achieve sustainable results
We propose that GLP-1 analogs are superior to DPP-4 inhibitors for managing pasireotide-induced hyperglycemia because GLP-1 analogs, unlike DPP-4 inhibitors, spare pasireotide-induced depletion of endogenous GLP-1 and restore insulin secretion suppressed by pasireotide through GLP-1R-Gs activation, counteracting the SSTRs-Gi axis
Retatrutide versus tirzepatide Tirzepatide (Zepbound, Mounjaro) activates both GLP-1 and GIP receptors
Your pharmacy will provide instructions on storage, handling, and proper technique
Results Disclaimer: Individual results vary and depend on multiple factors including adherence to treatment, provider guidance, diet, exercise, and individual health conditions